1. Home
  2. AMWL vs GBIO Comparison

AMWL vs GBIO Comparison

Compare AMWL & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMWL
  • GBIO
  • Stock Information
  • Founded
  • AMWL 2006
  • GBIO 2016
  • Country
  • AMWL United States
  • GBIO United States
  • Employees
  • AMWL N/A
  • GBIO N/A
  • Industry
  • AMWL Retail: Computer Software & Peripheral Equipment
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMWL Technology
  • GBIO Health Care
  • Exchange
  • AMWL Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • AMWL 165.7M
  • GBIO 166.2M
  • IPO Year
  • AMWL 2020
  • GBIO 2020
  • Fundamental
  • Price
  • AMWL $9.93
  • GBIO $2.69
  • Analyst Decision
  • AMWL Hold
  • GBIO Buy
  • Analyst Count
  • AMWL 4
  • GBIO 4
  • Target Price
  • AMWL $15.67
  • GBIO $7.50
  • AVG Volume (30 Days)
  • AMWL 52.9K
  • GBIO 74.2K
  • Earning Date
  • AMWL 10-30-2024
  • GBIO 11-07-2024
  • Dividend Yield
  • AMWL N/A
  • GBIO N/A
  • EPS Growth
  • AMWL N/A
  • GBIO N/A
  • EPS
  • AMWL N/A
  • GBIO N/A
  • Revenue
  • AMWL $254,911,000.00
  • GBIO $13,174,000.00
  • Revenue This Year
  • AMWL $3.68
  • GBIO $99.36
  • Revenue Next Year
  • AMWL $24.78
  • GBIO N/A
  • P/E Ratio
  • AMWL N/A
  • GBIO N/A
  • Revenue Growth
  • AMWL N/A
  • GBIO 1397.05
  • 52 Week Low
  • AMWL $5.00
  • GBIO $0.86
  • 52 Week High
  • AMWL $31.60
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • AMWL 62.85
  • GBIO 55.13
  • Support Level
  • AMWL $7.80
  • GBIO $2.41
  • Resistance Level
  • AMWL $10.37
  • GBIO $2.75
  • Average True Range (ATR)
  • AMWL 0.42
  • GBIO 0.19
  • MACD
  • AMWL 0.22
  • GBIO 0.04
  • Stochastic Oscillator
  • AMWL 79.46
  • GBIO 95.93

About AMWL American Well Corporation

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: